XML 48 R37.htm IDEA: XBRL DOCUMENT v3.21.2
Restructuring, Impairment, and Related Charges - Summary of Restructuring Charges (Details) - USD ($)
$ in Millions
3 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Restructuring Cost and Reserve [Line Items]    
Severance and employee-related costs, net $ 14 $ 38
Exit and other-related costs 40 13
Asset impairments and accelerated depreciation 104 5
Total 158 56
International    
Restructuring Cost and Reserve [Line Items]    
Total 6 14
Operating Segments | U.S. Pharmaceutical    
Restructuring Cost and Reserve [Line Items]    
Severance and employee-related costs, net 2 1
Exit and other-related costs 2 1
Asset impairments and accelerated depreciation 8 0
Total 12 2
Operating Segments | Prescription Technology Solutions    
Restructuring Cost and Reserve [Line Items]    
Severance and employee-related costs, net 0 0
Exit and other-related costs 1 0
Asset impairments and accelerated depreciation 17 0
Total 18 0
Operating Segments | Medical-Surgical Solutions    
Restructuring Cost and Reserve [Line Items]    
Severance and employee-related costs, net 0 0
Exit and other-related costs 2 3
Asset impairments and accelerated depreciation 4 0
Total 6 3
Operating Segments | International    
Restructuring Cost and Reserve [Line Items]    
Severance and employee-related costs, net 12 17
Exit and other-related costs 14 2
Asset impairments and accelerated depreciation 34 4
Total 60 23
Corporate    
Restructuring Cost and Reserve [Line Items]    
Severance and employee-related costs, net 0 20
Exit and other-related costs 21 7
Asset impairments and accelerated depreciation 41 1
Total $ 62 $ 28